Editorial on the article entitled “Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study”

Saphenous vein grafts (SVGs) are commonly used in coronary artery bypass graft (CABG) operations, but this procedure is burdened by leg secondary surgical-site infections (SSIs), lymphoedema, wound dehiscence, and potential skin flap necrosis. It is well recognized that the incidence of leg SSIs depends on the harvesting technique, and presents with a wide range of occurrence (1-4).